The future of damage assessment in vasculitis

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1357-1371

  Seo, Philip ^a   Luqmani, Raashid A ^b   Flossmann, Oliver ^c   Hellmich, Bernhard ^d   Herlyn, Karen ^d   Hoffman, Gary S ^e   Jayne, David ^f   Kallenberg, Cees G M ^g   Langford, Carol A ^e   Mahr, Alfred ^h   Matteson, Eric L ⁱ   Mukhtyar, Chetan B ^b   Neogi, Tuhina ^h   Rutgers, Abraham ^g   Specks, Ulrich ⁱ   Stone, John H ^a   Ytterberg, Steven R ⁱ   Merkel, Peter A ^h  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Mayo Clinic College of Medicine   (United States)

Author keywords

Damage; Outcomes; Vasculitis

Indexed keywords

ETANERCEPT; RITUXIMAB;

CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXERCISE; HUMAN; MENTAL DISEASE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RATING SCALE; REPRODUCIBILITY; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; VALIDATION PROCESS; VASCULITIS; VASCULITIS DAMAGE INDEX; WEGENER GRANULOMATOSIS;

DISABILITY EVALUATION; EUROPE; HUMANS; INTERNATIONAL COOPERATION; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VASCULITIS;

EID: 34250157096     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Exley AR, Bacon PA, Luqmani RA, et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371-80.
2. Merkel PA, Seo P, Aries P, et al. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol 2005;32:2488-95.
3. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-61.
4. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
5. De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:2461-9.
6. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002;23:450-68.
7. Seo P, Min YI, Holbrook JT, et al. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005;52:2168-78.
8. Stone JH, Holbrook JT, Marriott MA, et al. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum 2006;54:1608-18.
9. Merkel PA, Lo GH, Holbrook JT, et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005;142:620-6.
10. de Groot K, Jayne D. What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides. Clin Nephrol 2005;64:480-4.
11. Stone JH, Hoffman GS, Merkel PA, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2002;44:912-20.
12. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology Oxford 2002;41:572-81.
13. Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 2002;29:1398-400.
14. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index. Br J Rheumatol 1998;37:57-63.